1. The effects of Tripterygium wilfordii Hook F on renal outcomes in type 2 diabetic kidney disease patients with severe proteinuria: a single-center cohort study
   Yaqi Cheng et al, 2024, Renal Failure CrossRef
2. Targeting the Wnt/β-Catenin Signaling Pathway as a Potential Therapeutic Strategy in Renal Tubulointerstitial Fibrosis
   Shan-Shan Li et al, 2021, Frontiers in Pharmacology CrossRef
3. Phenylethanol Glycosides from Cistanche tubulosa Modulate the Gut Microbiota and Cecal Metabolites to Ameliorate Diabetic Nephropathy Induced by Streptozotocin Combined with High-Fat Diet in Rats
   Chong Ma et al, 2024, Journal of Medicinal Food CrossRef
4. Applications and Mechanisms of Tripterygium Wilfordii Hook. F. and its Preparations in Kidney Diseases
   Xue Tong et al, 2022, Frontiers in Pharmacology CrossRef
5. Research Progress of Chinese Herbal Medicine Intervention in Renal Interstitial Fibrosis
   Xiao-Yuan Liu et al, 2022, Frontiers in Pharmacology CrossRef
6. Shenkang injection improves chronic kidney disease by inhibiting multiple renin-angiotensin system genes by blocking the Wnt/β-catenin signalling pathway
   Yan-Ni Wang et al, 2022, Frontiers in Pharmacology CrossRef
7. Dapagliflozin Alleviates Renal Fibrosis by Inhibiting RIP1-RIP3-MLKL-Mediated Necroinflammation in Unilateral Ureteral Obstruction
   Mei Ying Xuan et al, 2022, Frontiers in Pharmacology CrossRef
8. The Active Compounds and Therapeutic Target of Tripterygium wilfordii Hook. f. in Attenuating Proteinuria in Diabetic Nephropathy: A Review
   Peng Liu et al, 2021, Frontiers in Medicine CrossRef
9. Efficacy and safety of Tripterygium wilfordii multiglucoside for idiopathic membranous nephropathy: a systematic review with bayesian meta-analysis
   Hongyun Wang et al, 2023, Frontiers in Pharmacology CrossRef